In the News

Bloomberg

Oliver Gao, director of Cornell’s Center for Transportation, Environment and Community Health, led an analysis on the impact of New York City’s congestion pricing initiative.

National Geographic

Nikica Zaninovic, Associate Professor of Embryology at Weill Cornell Medicine, contributed research showing AI can help determine embryo normality with about 70 percent accuracy.

Popular Science

Rebecca Gerdes, a Cornell University archaeologist, led a study that questions the identification of ancient olive oil residues in Mediterranean pottery.

Reuters

George Hay, a Cornell University law professor, analyzes the antitrust implications of Netflix’s acquisition of Warner Bros. Discovery’s streaming assets.

Bloomberg

Nupoor Narula, director of the Weill Cornell Medicine Women's Heart Program, discusses advancing detection of aortic aneurysms and the importance of research in women's cardiac health.

The Washington Post

Daniele Visioni, assistant professor of earth and atmospheric sciences, raises concerns about profit motives in the private geoengineering sector.

Gizmodo

A team of Cornell University researchers created the darkest fabric ever reported and collaborated with the Cornell Lab of Ornithology.

The New York Times

Dr. Costantino Iadecola, a professor of neurology at Weill Cornell Medicine, explains that most older adults with dementia have multiple disease factors present.

Popular Science

Trent Preszler, a professor of practice at Cornell University's Dyson School, is the author of the excerpted work and plays a notable role in the academic community.

CNBC

Sunita Sah, associate professor of management and organizations, shares strategies for parents to teach children how to practice appropriate defiance and assertiveness.

Reuters

Harry Katz, a Cornell University professor, provides analysis on the leverage workers hold in strikes like those at Starbucks. 

The Washington Post

Louis Aronne, director of the Comprehensive Weight Control Center at Weill Cornell Medicine, discusses amylin-based compounds as potential advances in weight loss medications.